Literature DB >> 8036524

The fibromyalgia syndrome: musculoskeletal pathophysiology.

S E Geel1.   

Abstract

Fibromyalgia (FM) is a chronic pain disorder that afflicts predominantly middle-aged women with cardinal symptoms of diffuse musculoskeletal pain, defined tender points, deprived sleep, and fatigue. The etiology and pathological mechanisms are poorly understood, and treatment approaches are largely ineffective. The clinical features of the syndrome are presented, and the relevance of muscle dysfunction in the etiopathogenesis of the disorder is explored. The evidence for involvement of muscle pathophysiology as a primary mechanism mediating the onset of symptoms is not compelling. Musculoskeletal dysfunction can be considered secondary to central abnormalities of pain modulation and altered sleep physiology precipitated by emotional stress in genetically predisposed individuals. Contemporary evidence favors treatment strategies that emphasize pain control, sleep enhancement, and a program of conditioning.

Entities:  

Mesh:

Year:  1994        PMID: 8036524     DOI: 10.1016/0049-0172(94)90030-2

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  15 in total

1.  Evidence for Somatic Hypersensitivity in Veterans With Gulf War Illness and Gastrointestinal Symptoms.

Authors:  QiQi Zhou; Meghan L Verne; Buyi Zhang; G Nicholas Verne
Journal:  Clin J Pain       Date:  2018-10       Impact factor: 3.442

Review 2.  Fibromyalgia: from pathophysiology to therapy.

Authors:  Tobias Schmidt-Wilcke; Daniel J Clauw
Journal:  Nat Rev Rheumatol       Date:  2011-07-19       Impact factor: 20.543

3.  Visceral algesia in irritable bowel syndrome, fibromyalgia, and sphincter of oddi dysfunction, type III.

Authors:  A Chun; S Desautels; A Slivka; C Mitrani; T Starz; C DiLorenzo; A Wald
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

Review 4.  [Fibromyalgia].

Authors:  M Späth
Journal:  Z Rheumatol       Date:  2011-09       Impact factor: 1.372

5.  Effects of the N-methyl-D-aspartate receptor on temporal summation of second pain (wind-up) in irritable bowel syndrome.

Authors:  QiQi Zhou; Donald D Price; Christopher S Callam; Michael A Woodruff; G Nicholas Verne
Journal:  J Pain       Date:  2010-12-13       Impact factor: 5.820

Review 6.  Diagnosis of osteoarthritis. Guidelines and current pitfalls.

Authors:  G Bálint; B Szebenyi
Journal:  Drugs       Date:  1996       Impact factor: 9.546

7.  Central and peripheral hypersensitivity in the irritable bowel syndrome.

Authors:  QiQi Zhou; Roger B Fillingim; Joseph L Riley; William B Malarkey; G Nicholas Verne
Journal:  Pain       Date:  2010-01-13       Impact factor: 6.961

8.  Ischemic hypersensitivity in irritable bowel syndrome patients.

Authors:  Qiqi Zhou; Roger B Fillingim; Joseph L Riley; G Nicholas Verne
Journal:  Pain Med       Date:  2010-10-01       Impact factor: 3.750

9.  Fibromyalgia and chronic fatigue syndrome: an update for athletic trainers.

Authors:  C R Cramer
Journal:  J Athl Train       Date:  1998-10       Impact factor: 2.860

10.  Evidence for autonomic dysregulation in the irritable bowel syndrome.

Authors:  Vishal Gupta; David Sheffield; G Nicholas Verne
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.